{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:02:31Z","timestamp":1793962951188,"version":"4.8.0"},"reference-count":39,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2023,3,7]]},"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:p>The range of lesions with a serrated appearance within the large intestine has expanded and become more complex over the last 30 years. The majority of these were previously known as metaplastic polyps but are today called hyperplastic polyps (HPs). HPs show two main growth patterns: microvesicular and goblet cell-rich. The former type shows morphological and molecular similarities (eg, <jats:italic>BRAF<\/jats:italic> mutations) to the more recently described sessile serrated lesion (SSL). In this review, we debate whether these lesions represent a biological spectrum or separate entities. Whichever view is held, microvesicular HPs and SSLs are distinct from the goblet cell-rich HP and the traditional serrated adenoma (TSA), which may themselves share molecular changes (eg, <jats:italic>KRAS<\/jats:italic> mutations), with the goblet cell-rich HP representing a precursor to the TSA. Both SSLs and the goblet cell-rich HP-TSA pathway are routes to colorectal cancer within the serrated pathway and overlaps between them can occur, for example, a (<jats:italic>BRAF<\/jats:italic>-mutated) TSA may arise from an SSL.<\/jats:p>","DOI":"10.1136\/jcp-2023-208783","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T13:21:37Z","timestamp":1678972897000},"page":"429-434","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Microvesicular hyperplastic polyp and sessile serrated lesion of the large intestine: a biological continuum or separate entities?"],"prefix":"10.1136","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2222-4104","authenticated-orcid":false,"given":"Adrian C","family":"Bateman","sequence":"first","affiliation":[{"name":"Department of Cellular Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1231-4117","authenticated-orcid":false,"given":"Adam L","family":"Booth","sequence":"additional","affiliation":[{"name":"Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5526-4220","authenticated-orcid":false,"given":"Raul S","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4228-6580","authenticated-orcid":false,"given":"Neil A","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Gloucestershire Cellular Pathology Laboratory, Cheltenham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"2025092501581080000_76.7.429.1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/his.14305","article-title":"The spectrum of serrated colorectal lesions-new entities and unanswered questions","volume":"78","author":"Bateman","year":"2021","journal-title":"Histopathology"},{"key":"2025092501581080000_76.7.429.2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.5858\/arpa.2020-0591-RA","article-title":"From mixed hyperplastic\/adenomatous polyp to sessile serrated lesion: a long and winding road for long and winding crypts","volume":"145","author":"Booth","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"2025092501581080000_76.7.429.3","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199006000-00003"},{"key":"2025092501581080000_76.7.429.4","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8608884"},{"key":"2025092501581080000_76.7.429.5","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2014-202175"},{"key":"2025092501581080000_76.7.429.6","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(200103)193:3<283::AID-PATH799>3.0.CO;2-9"},{"key":"2025092501581080000_76.7.429.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(03)00284-2"},{"key":"2025092501581080000_76.7.429.8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/ijc.34306","article-title":"Epidemiology of overall and early-onset serrated polyps versus conventional adenomas in a colonoscopy screening cohort","volume":"152","author":"Vithayathil","year":"2023","journal-title":"Int J Cancer"},{"key":"2025092501581080000_76.7.429.9","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2015-203016"},{"key":"2025092501581080000_76.7.429.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2014.04.064"},{"key":"2025092501581080000_76.7.429.11","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2013.126"},{"key":"2025092501581080000_76.7.429.12","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000141404.56839.6a"},{"key":"2025092501581080000_76.7.429.13","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2008.061960"},{"key":"2025092501581080000_76.7.429.14","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318158dde2"},{"key":"2025092501581080000_76.7.429.15","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1007\/s10620-018-5167-4","article-title":"Molecular profiling based on KRAS\/BRAF mutation, methylation, and microsatellite statuses in serrated lesions","volume":"63","author":"Sugai","year":"2018","journal-title":"Dig Dis Sci"},{"key":"2025092501581080000_76.7.429.16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/his.13846","article-title":"Clinicopathological factors associated with BRAF-V600E mutation in colorectal serrated adenomas","volume":"75","author":"Travaglino","year":"2019","journal-title":"Histopathology"},{"key":"2025092501581080000_76.7.429.17","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.3748\/wjg.v26.i42.6556","article-title":"What could microrna expression tell us more about colorectal serrated pathway carcinogenesis?","volume":"26","author":"Peruhova","year":"2020","journal-title":"World J Gastroenterol"},{"key":"2025092501581080000_76.7.429.18","unstructured":"Nagtegaal ID , Odze RD , Klimstra D , et al . WHO classification of tumours of the digestive system, vol 1. 5th edn. Lyon: International Agency for Research on Cancer, 2019."},{"key":"2025092501581080000_76.7.429.19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5946\/ce.2020.198","article-title":"Clinical features and predictors of dysplasia in proximal sessile serrated lesions","volume":"54","author":"Tan","year":"2021","journal-title":"Clin Endosc"},{"key":"2025092501581080000_76.7.429.20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.06.041"},{"key":"2025092501581080000_76.7.429.21","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/modpathol.2017.92","article-title":"Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry","volume":"30","author":"Liu","year":"2017","journal-title":"Mod Pathol"},{"key":"2025092501581080000_76.7.429.22","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.55"},{"key":"2025092501581080000_76.7.429.23","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31821537a2"},{"key":"2025092501581080000_76.7.429.24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAS.0000000000000531","article-title":"Loss of HES1 differentiates sessile serrated adenoma\/polyp from hyperplastic polyp","volume":"40","author":"Cui","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2025092501581080000_76.7.429.25","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2898"},{"key":"2025092501581080000_76.7.429.26","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318157f002"},{"key":"2025092501581080000_76.7.429.27","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13482"},{"key":"2025092501581080000_76.7.429.28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s00535-020-01673-z","article-title":"Clinicopathological and molecular correlations in traditional serrated adenoma","volume":"55","author":"Sekine","year":"2020","journal-title":"J Gastroenterol"},{"key":"2025092501581080000_76.7.429.29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/den.13603","article-title":"Macroscopic and microscopic morphology and molecular profiling to distinguish heterogeneous traditional serrated adenomas of the colorectum","volume":"32","author":"Chino","year":"2020","journal-title":"Dig Endosc"},{"key":"2025092501581080000_76.7.429.30","doi-asserted-by":"crossref","unstructured":"Li D , Doherty AR , Raju M , et al . Risk stratification for colorectal cancer in individuals with subtypes of serrated polyps. Gut 2021:gutjnl-2021-324301. doi:10.1136\/gutjnl-2021-324301","DOI":"10.1136\/gutjnl-2021-324301"},{"key":"2025092501581080000_76.7.429.31","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.11.046"},{"key":"2025092501581080000_76.7.429.32","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.11.1508"},{"key":"2025092501581080000_76.7.429.33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.humpath.2018.08.020","article-title":"Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression","volume":"83","author":"Acosta-Gonzalez","year":"2019","journal-title":"Hum Pathol"},{"key":"2025092501581080000_76.7.429.34","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2013-201608"},{"key":"2025092501581080000_76.7.429.35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13000-020-01057-0","article-title":"Hyperplastic polyp or sessile serrated lesion? The contribution of serial sections to reclassification","volume":"15","author":"Jaravaza","year":"2020","journal-title":"Diagn Pathol"},{"key":"2025092501581080000_76.7.429.36","unstructured":"Bosman FT , Carneiro F , Hruban RH , et al . WHO classification of tumours of the digestive system. 4th edn. Lyon: International Agency for Research on Cancer, 2010."},{"key":"2025092501581080000_76.7.429.37","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.161"},{"key":"2025092501581080000_76.7.429.38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319858"},{"key":"2025092501581080000_76.7.429.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2020.01.014"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2023-208783","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:58:22Z","timestamp":1758790702000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2023-208783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,6,19]]},"published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1136\/jcp-2023-208783"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2023-208783","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,16]]}}}